Login Register Cart 0
Generic placeholder image

Current Respiratory Medicine Reviews

Editor-in-Chief

ISSN (Print): 1573-398X
ISSN (Online): 1875-6387

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Mini-Review Article

Post-COVID-19 Pulmonary Hypertension: How it May Physiologically Affect Exercise Training

Author(s): Natiara Mohamad Hashim*, Muhammad Amin Ibrahim, Fatimah Ahmedy, Khairul Shafiq Ibrahim, Wan Najwa Wan Mohd Zohdi and Nor Faridah Ahmad Roslan

Volume 18, Issue 3, 2022

Published on: 05 July, 2022

Page: [171 - 178] Pages: 8

DOI: 10.2174/1573398X18666220526163255

Price: $65

Abstract

Exercise training is paramount in improving aerobic capacity, lung function, reducing the symptoms of dyspnea, and reconditioning the lean skeletal muscles. Many literature and guidelines have advocated the importance of exercise intervention in addressing the secondary impairment to post covid-19 infection, including home-based therapy and telerehabilitation. Pulmonary hypertension (PH) was previously thought to be contraindicated by exercise training; however, exercise was later found to be beneficial and relatively safe in chronic PH. However, there is a lack of highquality evidence on the safety and effectiveness of exercise training in post-COVID-19 infected individuals with PH. Pulmonary hypertension has been documented to be one of the post-COVID-19 complications. PH occurred due to COVID-19 infection should be carefully considered before subjecting them to exercise training, especially in home-based therapy. This article aims to discuss the differing etiological factor, pathophysiological backgrounds, and the possible disease long-term outcomes that may compromise the safety of exercise training in post-COVID-19 patients complicated with PH. By understanding the risk of developing PH, risk assessment and stratification can be explicitly outlined for a safe exercise prescription through proper patient selections. Any possible complications can be anticipated; hence, proper preventive strategies can be instituted.

Keywords: Post-COVID-19, exercise training, pulmonary hypertension, lung function, severe acute respiratory coronavirus, anxiety.

« Previous Next »
Graphical Abstract

[1]
Coronavirus disease (COVID-19) Weekly Epidemiological Update and Weekly Operational Update. Available from: https://www. who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports
[2]
Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19 syndrome. Nat Med 2021; 27(4): 601-15.
[http://dx.doi.org/10.1038/s41591-021-01283-z] [PMID: 33753937]
[3]
Nicholson AG, Osborn M, Devaraj A, Wells AU. COVID-19 related lung pathology: Old patterns in new clothing? Histopathology 2020; 77(2): 169-72.
[http://dx.doi.org/10.1111/his.14162] [PMID: 32881045]
[4]
Rinaldo RF, Mondoni M, Parazzini EM, et al. Deconditioning as main mechanism of impaired exercise response in COVID-19 survivors. Eur Respir J 2021; 58(2): 2100870.
[http://dx.doi.org/10.1183/13993003.00870-2021] [PMID: 33926969]
[5]
Lan Y, Liu W, Zhou Y. Right Ventricular Damage in COVID-19: Association Between Myocardial Injury and COVID-19. Front Cardiovasc Med 2021; 8: 606318.
[http://dx.doi.org/10.3389/fcvm.2021.606318] [PMID: 33665210]
[6]
Dhawan RT, Gopalan D, Howard L, et al. Beyond the clot: Perfusion imaging of the pulmonary vasculature after COVID-19. Lancet Respir Med 2020.
[PMID: 33217366]
[7]
Fabbri L, Moss S, Khan F, et al. Post-viral parenchymal lung disease of COVID-19 and viral pneumonitis: A systematic review and meta-analysis. medRxiv 2021.
[http://dx.doi.org/10.1101/2021.03.15.21253593]
[8]
Sim BLH, Chidambaram SK, Wong XC, et al. Clinical characteristics and risk factors for severe COVID-19 infections in Malaysia: A na-tionwide observational study. Lancet Regional Health-Western Pacific 2020; 4: 100055.
[http://dx.doi.org/10.1016/j.lanwpc.2020.100055] [PMID: 33521741]
[9]
Mishra A, Lal A, Sahu KK, George AA, Martin K, Sargent J. An update on pulmonary hypertension in Coronavirus Disease-19 (COVID-19). Acta Biomed 2020; 91(4): e2020155.
[PMID: 33525228]
[10]
Tudoran C, Tudoran M, Lazureanu VE, et al. Evidence of pulmonary hypertension after SARS-CoV-2 infection in subjects without previ-ous significant cardiovascular pathology. J Clin Med 2021; 10(2): 199.
[http://dx.doi.org/10.3390/jcm10020199] [PMID: 33430492]
[11]
Wittmer VL, Paro FM, Duarte H, Capellini VK, Barbalho-Moulim MC. Early mobilization and physical exercise in patients with COVID-19: A narrative literature review. Complement Ther Clin Pract 2021; 43: 101364.
[http://dx.doi.org/10.1016/j.ctcp.2021.101364] [PMID: 33743391]
[12]
Demeco A, Marotta N, Barletta M, et al. Rehabilitation of patients post-COVID-19 infection: A literature review. J Int Med Res 2020; 48(8): 300060520948382.
[http://dx.doi.org/10.1177/0300060520948382] [PMID: 32840156]
[13]
Zhu Y, Wang Z, Zhou Y, et al. Summary of respiratory rehabilitation and physical therapy guidelines for patients with COVID-19 based on recommendations of World Confederation for Physical Therapy and National Association of Physical Therapy. J Phys Ther Sci 2020; 32(8): 545-9.
[http://dx.doi.org/10.1589/jpts.32.545] [PMID: 32884178]
[14]
Mukaino M, Tatemoto T, Kumazawa N, et al. Staying active in isolation: Telerehabilitation for individuals with the severe acute respirato-ry syndrome coronavirus 2 infection. Am J Phys Med Rehabil 2020; 99(6): 478-9.
[http://dx.doi.org/10.1097/PHM.0000000000001441] [PMID: 32282339]
[15]
Jácome C, Marques A, Oliveira A, Rodrigues LV, Sanches I. Pulmonary telerehabilitation: An international call for action. Pulmonology 2020; 26(6): 335-7.
[http://dx.doi.org/10.1016/j.pulmoe.2020.05.018] [PMID: 32591279]
[16]
Spruit MA, Holland AE, Singh SJ, Tonia T, Wilson KC, Troosters T. COVID-19: Interim guidance on rehabilitation in the hospital and post-hospital phase from a European Respiratory Society-and American Thoracic Society-coordinated international task force. Eur Respir J 2020; 56(6): 2002197.
[http://dx.doi.org/10.1183/13993003.02197-2020] [PMID: 32817258]
[17]
Fowler RM, Gain KR, Gabbay E. Exercise intolerance in pulmonary arterial hypertension. Pulmonary medicine 2012; 2012 Article ID: 359204
[http://dx.doi.org/10.1155/2012/359204]
[18]
OLOPADE CO, BECK KC, VIGGIANO RW, STAATS BA, Eds.. Exercise limitation and pulmonary rehabilitation in chronic obstructive pulmonary disease.Mayo Clinic Proceedings. Elsevier 1992.
[19]
Pandey A, Garg S, Khunger M, et al. Efficacy and safety of exercise training in chronic pulmonary hypertension: Systematic review and meta-analysis. Circ Heart Fail 2015; 8(6): 1032-43.
[http://dx.doi.org/10.1161/CIRCHEARTFAILURE.115.002130] [PMID: 26185169]
[20]
Hasan SS, Capstick T, Ahmed R, et al. Mortality in COVID-19 patients with acute respiratory distress syndrome and corticosteroids use: A systematic review and meta-analysis. Expert Rev Respir Med 2020; 14(11): 1149-63.
[http://dx.doi.org/10.1080/17476348.2020.1804365] [PMID: 32734777]
[21]
Kochi AN, Tagliari AP, Forleo GB, Fassini GM, Tondo C. Cardiac and arrhythmic complications in patients with COVID-19. J Cardiovasc Electrophysiol 2020; 31(5): 1003-8.
[http://dx.doi.org/10.1111/jce.14479] [PMID: 32270559]
[22]
Horby P, Lim WS, Emberson JR, et al. Dexamethasone in hospitalized patients with COVID-19. N Engl J Med 2021; 384(8): 693-704.
[http://dx.doi.org/10.1056/NEJMoa2021436] [PMID: 32678530]
[23]
Ehlken N, Lichtblau M, Klose H, et al. Exercise training improves peak oxygen consumption and haemodynamics in patients with severe pulmonary arterial hypertension and inoperable chronic thrombo-embolic pulmonary hypertension: A prospective, randomized, con-trolled trial. Eur Heart J 2016; 37(1): 35-44.
[http://dx.doi.org/10.1093/eurheartj/ehv337] [PMID: 26231884]
[24]
Malenfant S, Lebret M, Breton-Gagnon É, et al. Exercise intolerance in pulmonary arterial hypertension: Insight into central and peripheral pathophysiological mechanisms. Eur Respir Rev 2021; 30(160): 200284.
[http://dx.doi.org/10.1183/16000617.0284-2020] [PMID: 33853885]
[25]
Taylor BJ, Shapiro BP, Johnson BD. Exercise intolerance in heart failure: The important role of pulmonary hypertension. Exp Physiol 2020; 105(12): 1997-2003.
[http://dx.doi.org/10.1113/EP088105] [PMID: 32092200]
[26]
Hilde JM, Skjørten I, Hansteen V, et al. Haemodynamic responses to exercise in patients with COPD. Eur Respir J 2013; 41(5): 1031-41.
[http://dx.doi.org/10.1183/09031936.00085612] [PMID: 22903957]
[27]
Grünig E, Maier F, Ehlken N, et al. Exercise training in pulmonary arterial hypertension associated with connective tissue diseases. Arthritis Res Ther 2012; 14(3): R148.
[http://dx.doi.org/10.1186/ar3883] [PMID: 22709477]
[28]
Becker-Grünig T, Klose H, Ehlken N, et al. Efficacy of exercise training in pulmonary arterial hypertension associated with congenital heart disease. Int J Cardiol 2013; 168(1): 375-81.
[http://dx.doi.org/10.1016/j.ijcard.2012.09.036] [PMID: 23041100]
[29]
Galiè N, Corris PA, Frost A, et al. Updated treatment algorithm of pulmonary arterial hypertension. J Am Coll Cardiol 2013; 62(25)(Suppl.): D60-72.
[http://dx.doi.org/10.1016/j.jacc.2013.10.031] [PMID: 24355643]
[30]
Weissmann N, Peters DM, Klöpping C, et al. Structural and functional prevention of hypoxia-induced pulmonary hypertension by indi-vidualized exercise training in mice. Am J Physiol Lung Cell Mol Physiol 2014; 306(11): L986-95.
[http://dx.doi.org/10.1152/ajplung.00275.2013] [PMID: 24705723]
[31]
Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pul-monary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol 2007; 50(7): e1-e157.
[http://dx.doi.org/10.1016/j.jacc.2007.02.013] [PMID: 17692738]
[32]
Barker-Davies RM, O’Sullivan O, Senaratne KPP, et al. The Stanford Hall consensus statement for post-COVID-19 rehabilitation. Br J Sports Med 2020; 54(16): 949-59.
[http://dx.doi.org/10.1136/bjsports-2020-102596] [PMID: 32475821]
[33]
Soril LJ, Stickland MK. Pulmonary rehabilitation for post-COVID-19 patients 2021.
[34]
Liu K, Zhang W, Yang Y, Zhang J, Li Y, Chen Y. Respiratory rehabilitation in elderly patients with COVID-19: A randomized controlled study. Complement Ther Clin Pract 2020; 39: 101166.
[http://dx.doi.org/10.1016/j.ctcp.2020.101166] [PMID: 32379637]
[35]
Spielmanns M, Pekacka-Egli A-M, Schoendorf S, Windisch W, Hermann M. Effects of a comprehensive pulmonary rehabilitation in se-vere post-COVID-19 patients. Int J Environ Res Public Health 2021; 18(5): 2695.
[http://dx.doi.org/10.3390/ijerph18052695] [PMID: 33800094]
[36]
Gloeckl R, Leitl D, Jarosch I, et al. Benefits of pulmonary rehabilitation in COVID-19: A prospective observational cohort study. ERJ Open Res 2021; 7(2): 00108-2021.
[http://dx.doi.org/10.1183/23120541.00108-2021] [PMID: 34095290]
[37]
Dhont S, Derom E, Van Braeckel E, Depuydt P, Lambrecht BN. The pathophysiology of ‘happy’hypoxemia in COVID-19. Respir Res 2020; 21(1): 1-9.
[http://dx.doi.org/10.1186/s12931-020-01462-5] [PMID: 31898493]
[38]
Emtner M, Porszasz J, Burns M, Somfay A, Casaburi R. Benefits of supplemental oxygen in exercise training in nonhypoxemic chronic obstructive pulmonary disease patients. Am J Respir Crit Care Med 2003; 168(9): 1034-42.
[http://dx.doi.org/10.1164/rccm.200212-1525OC] [PMID: 12869359]
[39]
Gloeckl R, Marinov B, Pitta F. Practical recommendations for exercise training in patients with COPD. Eur Respir Rev 2013; 22(128): 178-86.
[http://dx.doi.org/10.1183/09059180.00000513] [PMID: 23728873]
[40]
Shmueli H, Shah M, Ebinger JE, et al. Left ventricular global longitudinal strain in identifying subclinical myocardial dysfunction among patients hospitalized with COVID-19. Int J Cardiol Heart Vasc 2021; 32: 100719.
[http://dx.doi.org/10.1016/j.ijcha.2021.100719] [PMID: 33521240]
[41]
Gupta N, Agrawal S, Chakrabarti S, Ish P. COPD 2020 Guidelines - what is new and why? Adv Respir Med 2020; 88(1): 38-40.
[http://dx.doi.org/10.5603/ARM.2020.0080] [PMID: 32153009]
[42]
George PM, Barratt SL, Condliffe R, et al. Respiratory follow-up of patients with COVID-19 pneumonia. Thorax 2020; 75(11): 1009-16.
[http://dx.doi.org/10.1136/thoraxjnl-2020-215314] [PMID: 32839287]

Rights & Permissions Print Cite
Article Metrics
9
© 2024 Bentham Science Publishers | Privacy Policy